Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 3,685-3,696 of 4,306
Drug study icon
CompletedNCT00148564

Energy Homeostasis Under Treatment With Atypical Antipsychotics

This summary needs review. Please check the official study record and contact the research team for details.

In Berlin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
Germany
Sponsor
Charite University, Berlin, Germany
Condition
Schizophrenia
Other study type icon
CompletedNCT06960811

Epileptic Psychoses and Their Link With Ictal Emotions and Consciousness

This summary needs review. Please check the official study record and contact the research team for details.

In Nancy
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
France
Sponsor
Central Hospital, Nancy, France
Condition
Schizophrenia
Drug study icon
CompletedNCT00634361

Ethyl-EPA Treatment of Prodromal Patients

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 14 Years to 35 Years
Countries
Sponsor
Yale University
Condition
Schizophrenia
Other study type icon
CompletedNCT02006862

eVAluatIon of OLanzapine TreatmEnT

This summary needs review. Please check the official study record and contact the research team for details.

In Athens
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, BipolarityObservationalFrom 18 Years to 90 Years
Countries
Greece
Sponsor
Elpen Pharmaceutical Co. Inc.
Condition
Schizophrenia, Bipolarity
Drug study icon
CompletedNCT00448890

Evaluation of Single and Repeat Doses of GSK729327 in Healthy Volunteers

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Berlin
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United Kingdom, Germany
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02440906

Evaluation of the Texas Wellness Incentives and Navigation (WIN) Project

This summary needs review. Please check the official study record and contact the research team for details.

In Gainesville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 21 Years to 55 Years
Countries
United States
Sponsor
University of Florida
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06054061

Evaluation the Efficacy "Think and Cope Positively" Program

This summary needs review. Please check the official study record and contact the research team for details.

In Madrid
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 65 Years
Countries
Spain
Sponsor
Universidad Pontificia Comillas
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.